HR 2197 · 119th CongressIn Committeecongress.gov ↗
What this bill does
AI plain-language summaryThis bill appears to concern the 340B drug pricing program and would restrict its use for transgender care. No official summary is available for this bill.
Sponsor
Rep. Johnson, Dusty [R-SD-At Large]
R
Introduced
March 18, 2025
Policy Area
Health
Your Vote
Discussion (0)
Explain what is at stake in this bill.
Sign in to join the discussion.
No comments yet. Be the first.